Related Experiment Video
Updated: Jun 24, 2026
08:53
Synthesis, Functionalization, and Characterization of Fusogenic Porous Silicon Nanoparticles for Oligonucleotide Delivery
Published on: April 16, 2019
Peptide-functionalized nanogels for targeted siRNA delivery
William H Blackburn1, Erin B Dickerson, Michael H Smith
1Petit Institute for Bioengineering and Bioscience, Georgia Institute of Technology, Atlanta, GA 30332, USA.
Bioconjugate Chemistry
|April 4, 2009
Summary
Novel nanogels carrying small interfering RNA (siRNA) target ovarian cancer cells by binding to Eph2A receptors. These non-toxic nanogels effectively deliver siRNA for gene silencing, overcoming a key challenge in siRNA therapy development.
Area of Science:
- Biotechnology
- Nanomedicine
- Oncology
Background:
- Developing effective siRNA therapies is hindered by delivery challenges to target cells and tissues.
- Efficient cell membrane passage and subsequent mRNA silencing are critical for siRNA efficacy.
- Targeting specific cancer cell receptors is a key strategy for precision medicine.
Purpose of the Study:
- To synthesize and characterize novel core/shell hydrogel nanoparticles (nanogels) for targeted siRNA delivery.
- To functionalize nanogels with peptides that specifically bind to ovarian carcinoma cells expressing the Eph2A receptor.
- To evaluate the efficacy, safety, and gene silencing potential of these nanogels in vitro.
Main Methods:
- Synthesis of core/shell hydrogel nanoparticles (nanogels) with surface-localized peptides.
- Noncovalent encapsulation of small interfering RNA (siRNA) within the nanogels.
- In vitro evaluation of nanogel targeting specificity, cell toxicity, viability, and gene silencing (EGF receptor knockdown).
Main Results:
- Nanogels effectively encapsulated siRNA and demonstrated cell-specific delivery to ovarian carcinoma cells in serum-containing medium.
- Cell toxicity and viability assays confirmed the nanogel construct is non-toxic.
- Preliminary gene silencing experiments showed successful knockdown of the EGF receptor mediated by nanogel-delivered siRNA.
Conclusions:
- The developed nanogels represent a promising platform for targeted siRNA delivery in ovarian cancer therapy.
- The nanogel system effectively protects siRNA during cellular uptake and facilitates endosomal escape for gene silencing.
- These findings address a major bottleneck in siRNA therapy development, paving the way for potential clinical applications.
Related Concept Videos
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
02:30siRNA - Small Interfering RNAs
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...